Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2019-07-31 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于股权激励限制性股票回购注销实施的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company regarding the repurchase and cancellation of restricted stock related to an equity incentive plan. It details the reasons for the repurchase, the number of shares involved, the decision-making process, and legal opinions. The document does not contain financial statements or detailed financial performance data but is a disclosure about a capital change event (repurchase and cancellation of shares). It is not an annual report, audit report, earnings release, or any other financial report type. It fits the category of Share Issue/Capital Change announcements, which include share repurchases and cancellations.
2019-07-31 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a new veterinary drug registration certificate. It details the approval process, product information, and significance to the company. It is a regulatory announcement about a new product approval, not a financial report, management change, or shareholder meeting material. The document is short (1204 characters) and serves as an official notice of a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-07-04 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company about receiving a new veterinary drug registration certificate from the Ministry of Agriculture and Rural Affairs. It details the product information, development process, market background, and significance to the company. The document is short (1512 characters) and serves as a formal notification of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management changes. It is not a report itself but an announcement of a regulatory milestone. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-07-04 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company about receiving a new veterinary drug registration certificate from the Ministry of Agriculture and Rural Affairs. It details the drug's information, development process, market background, and significance to the company. The document is short (1278 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or other report content. Therefore, it fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-07-04 Chinese
关于对暂时闲置自有资金进行现金管理的实施公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 普莱柯生物工程股份有限公司 regarding the implementation of cash management for temporarily idle own funds. It details agreements with banks for structured deposits and wealth management products, including amounts, terms, and expected returns. The document includes risk control measures, impact on company operations, and a summary of transactions over the past twelve months. It is a formal disclosure of financing activities related to cash management and investment of idle funds, not a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion of results, nor is it a regulatory certification or voting result. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital management.
2019-06-28 Chinese
关于子公司投资永修观由昭德股权投资基金中心（有限合伙）的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 普莱柯生物工程股份有限公司 regarding its subsidiary's investment in an equity investment fund. It details the investment amount, fund management, investment scope, and potential risks. There are no financial statements, quarterly or annual results, or audit information. The document is a regulatory announcement about a capital investment transaction, specifically an external investment by a subsidiary into a fund. It is not a full financial report, earnings release, or management discussion. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through investment activities.
2019-06-24 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.